UCB
The PIM Outcomes Research Lead plays a critical role in advancing evidence generation across the Patient Impact organization, serving as a strategic advisor to help country and regional teams develop impactful evidence initiatives. This position involves shaping evidence generation strategies, providing scientific guidance on outcomes research and real-world evidence, and ensuring compliance with quality standards. The role requires influencing stakeholders in a global matrix environment to support healthcare decision-making and improve patient outcomes.
Headquarters
Brussels, Brussels, Belgium
Company Size
5001-10000 employees
Founded
1928
UCB a global biopharmaceutical leader focuses on creating valuable solutions that improve the lives of people living with neurological and autoimmune conditions
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for UCB.
UCB didn’t post a salary, so this is our estimate from similar listings.
Director, Global Real-World Evidence & Health Outcomes Research Scientist
GSK plc
Director, US Real-World Evidence and Health Outcomes – Oncology Pipeline
GSK plc
Director, US Real-World Evidence & Health Outcomes Research Scientist Hematology-Oncology
GSK plc
Director, Respiratory Biologics - Global Real-World Evidence & Health Outcomes
lifelancer
Director, Respiratory Biologics - Global Real-World Evidence & Health Outcomes
lifelancer
Director, Global Real-World Evidence & Health Outcomes Scientist, Oncology
GSK plc